Tevogen Bio Holdings Inc. (NASDAQ: TVGN) Executes Reverse Stock Split

Core Viewpoint - Tevogen Bio Holdings Inc. executed a reverse stock split to meet Nasdaq's minimum bid price requirement, aiming to stabilize its stock value and enhance attractiveness to investors [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split was approved by stockholders on February 19, 2026, allowing the Board to set the final ratio [2]. - The split ratio was set at 50 for 1, converting every 50 shares into one share [2]. - Following the split, the stock trades under the same symbol but with a new CUSIP number, 88165K 200 [3]. Group 2: Stock Performance and Market Data - The current stock price is $6.84, reflecting an 11.74% decrease, equating to a change of $0.91 [3]. - The stock has shown significant volatility, with a daily trading range between $6.22 and $10.76 [4]. - Over the past year, the stock reached a high of $75.50 and a low of $6.22, with a market capitalization of approximately $27.57 million [4]. - The trading volume for the day is reported at 190,619 shares, indicating active trading despite the stock's challenges [4].